Catalyst Funds Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-56,600	Closed	-$135K	–	1233
2024 Q1	$135K	Buy	+56,600	New	+$135K	0.04%	340